CAR-Macrophage Therapy Alleviates Myocardial Ischemia-Reperfusion Injury

Abstract

Our proof-of-concept study demonstrates the therapeutic potential of FAP CAR-Ms in alleviating myocardial I/R and potentially opens new avenues for the treatment of a range of heart diseases that include a fibrotic phenotype.